Abstracts

362 – CD4-Binding Site Abs Modify the Negative Association Between Cluster A Abs and CD4 Count in PWH

Background Chronic inflammation and immune dysfunction persist in some people with HIV (PWH), even during antiretroviral therapy (ART). We previously observed that HIV-1 soluble gp120 (sgp120) and a family of gp120-specific anti-cluster A antibodies (Abs) are associated with chronic inflammation and immune dysfunction in aviremic participants of the Canadian HIV and Aging cohort. Here, we…

375 – HIV-Encoded Proteins Induce Pulmonary Arterial Hypertension via Increases in Podocan-Like Protein 1

Background Thanks to the advent of combination antiretroviral therapy (cART), life expectancy has dramatically increased in people with HIV (PWH), and the spectrum of diseases related to HIV has shifted towards non-infectious chronic illnesses, including cardiopulmonary disorders. Pulmonary arterial hypertension (PAH) is amongst the most devastating cardiovascular complications of HIV. Pulmonary artery smooth muscle cells…

494 – Loss of Virologic Control 32 Years After HIV-1 Diagnosis in an Exceptional Elite Controller

Background HIV-1 Exceptional Elite Controllers (EEC) maintain undetectable viremia and halt disease progression more than 20 years after infection in the absence of treatment and may be considered as functionally cured.  However, loss of control in these individuals is unknown. In this study we performed a detailed, longitudinal characterisation of the HIV-1 reservoir, viral evolution…

849 – ALDH Activity as a New Marker of Subclinical Atherosclerosis During ART-Treated HIV-1 Infection

Background Antiretroviral therapy (ART) controls viral replication in people with HIV (PWH), but viral reservoirs (VR) persist and represent a cause for the occurrence of age-related comorbidities, e.g. cardiovascular disease (CVD). We demonstrated that retinoic acid (RA, a vitamin A derivative) increases HIV-1 outgrowth from VR and that microbiota components (e.g., Staphylococcus aureus) promote ALDH…

397 – Analysis of SIV Envelope Diversity During Untreated Infection

Background Viral diversification complicates immune-based cure strategies. SIV-infected Rhesus macaques (RMs) treated with antiretroviral therapy (ART) provide insights into viral dynamics and reservoir persistence in people with HIV-1. We previously described a shift in the composition of infected cell populations during ART, with recently infected cells harboring mutated proviruses decaying more rapidly, and ancestral variants…

394 – Immunometabolic Reprogramming by Caloric Restriction Leads to Protection From SIV in Rhesus Macaques

Background Nutrient metabolism influences HIV-1 replication, immunity, and chronic inflammation but is difficult to target therapeutically. We hypothesized that regulating metabolism via caloric restriction (CR), a safe, anti-aging modality with anti-inflammatory effects could improve SIV disease outcome in rhesus macaques (RMs). Methods Healthy, non-obese, adult male and female RMs (n=6) were experimentally restricted to consume…